Related Experiment Video

Updated: May 16, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

Notch signaling in pediatric soft tissue sarcomas

Rossella Rota1, Roberta Ciarapica, Lucio Miele

  • 1Department of Oncohematology, Ospedale Pediatrico Bambino Gesù, IRCCS, Piazza Sant'Onofrio 4, Roma, 00165, Italy. rossella.rota@opbg.net

BMC Medicine
|November 20, 2012
PubMed

Insights

Pediatric soft tissue sarcomas involve abnormal Notch signaling. Targeting this pathway offers new treatment opportunities for these rare childhood cancers, improving patient outcomes.

Area of Science:

  • Pediatric Oncology
  • Molecular Biology
  • Cancer Signaling Pathways

Background:

  • Pediatric soft tissue sarcomas are rare childhood cancers often driven by chromosomal translocations.
  • Current treatments face challenges with metastatic and aggressive forms, leading to poor survival rates.
  • These sarcomas are believed to originate from embryonic mesenchymal progenitor cells with aberrant signaling.

Purpose of the Study:

  • To review recent evidence on the role of Notch signaling in pediatric soft tissue sarcomas.
  • To highlight the importance of Notch signaling in tumor cell biology.
  • To discuss potential therapeutic strategies targeting Notch signaling.

Main Methods:

  • Literature review of recent research on Notch signaling in pediatric soft tissue sarcomas.
  • Analysis of the molecular mechanisms underlying Notch pathway dysregulation in these tumors.
  • Discussion of preclinical and clinical data related to Notch-targeted therapies.

Main Results:

  • Notch signaling pathway dysregulation is implicated in the development and progression of pediatric soft tissue sarcomas.
  • Aberrant Notch signaling influences key cellular processes, including proliferation and differentiation.
  • Emerging evidence suggests Notch pathway components as potential therapeutic targets.

Conclusions:

  • Notch signaling plays a critical role in the biology of pediatric soft tissue sarcomas.
  • Targeting the Notch pathway presents a promising avenue for novel therapeutic interventions.
  • Further research is needed to optimize Notch-targeted therapies for improved clinical outcomes.

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...